Carbonic anhydrase VA deficiency: a very rare case of hyperammonemic encephalopathy.


Journal

Journal of pediatric endocrinology & metabolism : JPEM
ISSN: 2191-0251
Titre abrégé: J Pediatr Endocrinol Metab
Pays: Germany
ID NLM: 9508900

Informations de publication

Date de publication:
18 Aug 2020
Historique:
received: 12 03 2020
accepted: 22 05 2020
pubmed: 19 8 2020
medline: 16 6 2021
entrez: 19 8 2020
Statut: epublish

Résumé

Objectives Carbonic anhydrase VA (CAVA) deficiency is a rare autosomal recessive inborn error of metabolism that leads to acute metabolic crises, especially in the neonatal or infantile period. It is caused by a deficiency of the enzyme CAVA, which is encoded by the CA5A gene. Case presentation Fifteen patients with homozygous pathogenic CA5A mutations involving 10 different lesions have been reported in the literature up to date. Main clinical and biochemical features of CAVA deficiency include lethargy, hyperammonemic encephalopathy, metabolic acidosis, elevated lactate and hypoglycemia. In most patients reported so far, a single metabolic decompensation attack has been reported, and they have remained stable thereafter with no further crisis. Conclusions We report the 16th case of CAVA deficiency, who was diagnosed by whole-exome sequencing and showed a typical course of the disease with normal development at 18 months.

Identifiants

pubmed: 32809955
doi: 10.1515/jpem-2020-0117
pii: /j/jpem.ahead-of-print/jpem-2020-0117/jpem-2020-0117.xml
doi:
pii:

Substances chimiques

Carbonic Anhydrase V EC 4.2.1.-

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1349-1352

Auteurs

Asburce Olgac (A)

Department of Pediatric Metabolism, Dr. Sami Ulus Maternity and Child Health Training and Research Hospital, Ankara, Turkey.

Cigdem Seher Kasapkara (CS)

Department of Pediatric Metabolism, Dr. Sami Ulus Maternity and Child Health Training and Research Hospital, Ankara, Turkey.

Mustafa Kilic (M)

Department of Pediatric Metabolism, Dr. Sami Ulus Maternity and Child Health Training and Research Hospital, Ankara, Turkey.

Ebru Yılmaz Keskin (EY)

Department of Pediatric Hematology and Oncology, Süleyman Demirel University Medical Faculty, Isparta, Turkey.

Gonca Sandal (G)

Department of Neonatology, Süleyman Demirel University Medical Faculty, Isparta, Turkey.

David Stephen Cram (DS)

Berry Genomics Corporation, Beijing, 100015, China.

Johannes Haberle (J)

Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.

Deniz Torun (D)

Department of Medical Genetics, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH